Cannabis in South Africa: The Rainbow Nation Leads the Continent

Home | Canna Law Blog | Cannabis in South Africa: The Rainbow Nation Leads the Continent South Africa is one of the few jurisdictions outside North America that has legalized recreational cannabis, albeit under very limited circumstances. Appropriately for a country belonging to the common-law tradition, legalization was not the result of a legislative enactment, but rather of a 2018 decision by the Constitutional Court ("ConCourt") of South Africa, which partially upheld a ruling by a lower court in the Western Cape. In its decision, the ConCourt found unconstitutional the statutory provisions that criminalized the use and possession of cannabis in private, as well as cultivation in a private place for personal consumption. This finding of unconstitutionality was based on section 14 of South African Constitution, which enshrines a right to privacy that includes the right of persons not to have their persons, homes, or property searched, or their possessions seized. However, the ConCourt did not extend the reasoning to include the purchase of cannabis, as the lower court had. The ConCourt decision enjoined the South African Parliament to repeal the laws in question within two years. On September 1, 2020, the Cannabis for Private Purposes Bill was introduced. This bill would codify the legal framework mandated by the ConCourt decision. Consistent with that decision, selling cannabis would remain a criminal offense, save for some limited exceptions. Turning to medical use, in general both CBD and THC products require a prescription. In the case of THC, a scheduling exception has been made to accomodate the ConCourt decision. Processed cannabis products containing 0.001% THC or less are also exempt as well, to permit the unrestricted sale of certain CBD products. Processed hemp fiber and its products are also exempt, as long as they contain no more than 0.1% THC. In 2020, the South African Health Products Regulatory Authority (SAHPRA) exempted some CBD medicinal products from this requirement. According to a 2020 SAHPRA notice, a prescription is not required for CBD products that are: complementary medicines containing no more than 600 mg cannabidiol per sales pack, providing a maximum daily dose of 20 mg of cannabidiol, and making a general health enhancement, health maintenance or relief of minor symptoms (low-risk) claim or processed products from cannabis raw raw plant material intended for ingestion containing 0.0075 percent or less of cannabidiol where only the naturally occurring quantity of cannabinoids found in the source material are contained in the product. The CBD exemptions do not extend to foodstuffs. According to SAHPRA, "CBD as an additive or ingredient is not permissible in foodstuffs," with only naturally occurring trace amounts deemed acceptable. SAHPRA guidance also suggests that cosmetics are subject to the same restriction; this is consistent with reports of seizures of imported products. In conclusion, credit must be given to the South African authorities for moving past generalizations when it comes to CBD, a common sense approach that would be welcomed elsewhere. As for recreational cannabis, the ConCourt decision is a promising start, but legal avenues should also exist for those who are not blessed with a green thumb or otherwise cannot grow at home. We will be keeping an eye out for further developments, and see if the Rainbow Nation continues to be Africa's cannabis pioneer. Check Out Our Cannabis Law Services Share Twitter Facebook LinkedIn E-mail Comment Fred Rocafort Fred leads Harris Sliwoski’s intellectual property practice and is the coordinator of the firm’s international team. Much of Fred’s practice consists of helping cannabis businesses protect their brands. He also works with entrepreneurs and companies entering the Web3 space, a new frontier for IP law. Prior to joining Harris Sliwoski, Fred worked overseas for more than a decade, in both government and private sector roles. Fred is a regular contributor to the award-winning China Law Blog and Canna Law Blog. Fred began his career overseas as a U.S. consular officer in Guangzhou, China, where he advocated for fairer treatment of American companies and citizens in China and for stronger intellectual property rights enforcement. After entering the private sector, Fred worked at a Shanghai law firm as a foreign legal advisor and later joined one of the oldest American law firms in China, helping foreign companies navigate the Chinese legal environment. He also led the legal team at a Hong Kong-based brand protection consultancy, spending most of his time out in the field, protecting clients against counterfeiters and fraudsters in Greater China, Southeast Asia and Latin America. In addition to his IP work, as a native Spanish speaker, Fred works closely with different Harris Sliwoski teams on Latin America and Spain matters. Fred also provides advice to cannabis industry participants and other businesses on import and export transactions. Fred is an ardent supporter of FC Barcelona—and would be even in the absence of Catalan forebears who immigrated to Puerto Rico in the mid-1800s. Harris Sliwoski Attorney Read more posts [email protected] Read More Hemp/CBD, International Cannabis Law, Recreational Marijuana Related Posts September 25, 2026 DEA Enforcement in a Changing Cannabis Landscape: Rescheduling, Hemp, and What Comes Next September 17, 2026 The Supreme Court May Decide if Cannabis-Related Residency Requirements are Unconstitutional September 16, 2026 A $31.8 Million Cannabis-Related Verdict That a Federal Court Wouldn’t Enforce September 15, 2026 Jason Adelstone Moderates Federal Cannabis Policy Discussion at IgniteIt Denver September 11, 2026 Medical Marijuana in Schedule III Survives Its First Major Challenge September 10, 2026 How to Acquire a Colorado Cannabis License September 4, 2026 The Intoxicating Hemp Products Ban Was Delayed a Month. Now What? August 31, 2026 Is the Global Shift to the Right Threatening International Cannabis Reforms? August 28, 2026 Oregon Cannabis Roundup: Fall 2026 August 26, 2026 Five Bills Every California Cannabis Operator Needs to Track in 2026 August 14, 2026 California Cannabis Contracts After Rescheduling: Why Your Contracts Need a Second Look August 4, 2026 DCC License Conversions After Rescheduling: How and When to Split A/M Licenses in California August 3, 2026 The Contradictions of Cannabis Law: From the United States to International Treaties July 28, 2026 What California Operators Must Do After Rescheduling: DEA Registration, License Restructuring, and 280E July 24, 2026 Medical Marijuana Schedule III Litigation: The D.C. Circuit's First Major Test Leave a comment Cancel reply